Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 19:11:1497501.
doi: 10.3389/fmed.2024.1497501. eCollection 2024.

Photobiomodulation therapy for congenital color vision deficiency: results of a preliminary randomized clinical trial

Affiliations

Photobiomodulation therapy for congenital color vision deficiency: results of a preliminary randomized clinical trial

Yidi Liu et al. Front Med (Lausanne). .

Abstract

Purpose: This study presents a novel randomized controlled trial investigating photobiomodulation (PBM) therapy as an intervention method for color vision deficiency (CVD).

Methods: A total of 74 participants with CVD were assigned to either the PBM group or the control group. In the PBM group, participants wore virtual reality (VR) goggles twice daily, with a 12-h interval, over a four-week period. The VR video consisted of alternating red and green images, each presented for 5 s, totaling 6 min and 20 s. No treatment was administered to the control group. Color vision improvement was assessed using Yu's, Ishihara's pseudoachromatic plates, Color Blindness Check (CBC), and FM-100 Hue total error score (TES).

Results: After 4 weeks, in terms of Yu's and Ishihara's Plates, the patients in PBM group could identify increasing pieces (before: 1.6 ± 1.6, 2.3 ± 2.2; 4 weeks: 6.5 ± 4.4, 5.4 ± 2.9), while in control group, the number was before: 2.6 ± 3.4, 2.6 ± 2.5; 4 weeks: 3.3 ± 3.6, 2.9 ± 2.2. As for CBC scores, the patients in PBM also showed improved high scores (before: 2353.3 ± 700.0; 4 weeks: 2693.6 ± 642.5). Moreover, PBM treatment resulted in a significant reduction of FM-100 scores (before: 298.0 ± 211.3; 4 weeks: 202.1 ± 114.4).

Conclusion: These findings suggest that PBM therapy holds promise as a potential treatment option for individuals with CVD.

Clinical trial registration: The study received approval from the Ethics Committee of PLA General Hospital, China (KY2021-017). Additionally, it was registered as a Chinese domestic clinical trial (ChiCTR2200056761) at "http://Chictr.org.cn/index.aspx".

Keywords: color vision deficiency; deutan; photobiomodulation; phototherapy; protan.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The assumption of PBM treating CVD.
Figure 2
Figure 2
Trial profile.
Figure 3
Figure 3
The wavelength of therapeutic light.
Figure 4
Figure 4
Color vision changes in the PBM and control groups. (“CBC” is an abbreviation for “Color Blindness Check”, “FM-100 TES” is an abbreviation for “FM-100 Hue Total Error Score”).

Similar articles

References

    1. Hovis JKJO, Science V. Diagnosis of Defective Colour Vision, vol. 79. 2nd ed. Boston: Butterworth-Heinemann; (2002). 406 p.
    1. Deeb SS. Molecular genetics of colour vision deficiencies. Clin Exp Optom. (2004) 87:224–9. doi: 10.1111/j.1444-0938.2004.tb05052.x - DOI - PubMed
    1. Slaby D, Roberts J. Color vision deficiencies in youths 12-17 years of age, United States. Vital and health statistics Series 11, Data from the National Health Survey. (1974) 134:1–41. PMID: - PubMed
    1. Chia A, Gazzard G, Tong L, Zhang X, Sim EL, Fong A, et al. . Red-green colour blindness in Singaporean children. Clin Experiment Ophthalmol. (2008) 36:464–7. doi: 10.1111/j.1442-9071.2008.01799.x - DOI - PubMed
    1. Xie JZ, Tarczy-Hornoch K, Lin J, Cotter SA, Torres M, Varma R, et al. . Color vision deficiency in preschool children: the multi-ethnic pediatric eye disease study. Ophthalmology. (2014) 121:1469–74. doi: 10.1016/j.ophtha.2014.01.018, PMID: - DOI - PMC - PubMed

LinkOut - more resources